- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about PCVX
Recent news which mentions PCVX
Vaccine Player Vaxcyte Can Potentially Disrupt Pfizer's 20-Plus-Year Near Monopoly, Says Analyst
December 07, 2023
From Benzinga
Where Is The Current Bull Market? Scan Of Stocks Gaining Over 20% Over The Past Week Almost Exclusively Yields Biotech Names
April 20, 2023
From Benzinga
From Benzinga
Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 17, 2023
From Benzinga
Earnings Scheduled For February 27, 2023
February 27, 2023
From Benzinga
From Benzinga
Tesla To $205? Here Are 10 Other Price Target Changes For Tuesday
January 03, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2022
December 16, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022
December 15, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022
November 17, 2022
From Benzinga
Why Shares of Vaxcyte Rose 110.7% This Week
October 29, 2022
From Motley Fool
Wingstop, Harley-Davidson, Rollins And Some Other Big Stocks Moving Higher On Wednesday
October 26, 2022
From Benzinga
From Benzinga
Avis Budget, Scholastic And Other Big Gainers From Monday
October 25, 2022
From Benzinga
Dow Rises 1.5%; Nasdaq Jumps Over 100 Points
October 24, 2022
From Benzinga
Why Vaxcyte Shares Are Trading Sharply Higher? Here Are 63 Stocks Moving In Monday's Mid-Day Session
October 24, 2022
From Benzinga
Nasdaq Turns Higher; Applied Genetic Technologies Shares Surge
October 24, 2022
From Benzinga
Vaxcyte Shares Surge As Its Pneumococcal Vaccine On Par With Pfizer's Shot In Study
October 24, 2022
From Benzinga
Why Is Tricida (TCDA) Stock Down 90% Today?
October 24, 2022
From InvestorPlace
Why Is Vaxcyte (PCVX) Stock Up 70% Today?
October 24, 2022
From InvestorPlace
US Stocks Mixed; Dow Jumps 200 Points
October 24, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 24, 2022
From Benzinga
From InvestorPlace
Vaxcyte Completes Enrolment In Mid-Stage Pneumococcal Disease Study, Sees Top-line Data In H1 2013
September 06, 2022
Tickers
PCVX
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.